Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

Peccatori N;Curto A;Silvestri D;Rebellato S;Antić Ž;Nebral K;Bergmann AK;Strehl S;Zimmermann M;Saitta C;Palmi C;Bardini M;Bhatia S;Borkhardt A;Quadri M;Guardo D;Lo Nigro L;Parasole R;Caterina Putti M;Locatelli F;Alten J;Stanulla M;Buldini B;Sarno J;Davis KL;Conter V;Balduzzi AC;Valsecchi MG;Biondi A;Attarbaschi A;Schrappe M;Cario G;Rizzari C;Cazzaniga G;Fazio G.

2026